Patients diagnosed with aortic valve stenosis requiring isolated aortic valve replacement, as well as patients with the additional need of concomitant bypass surgery were included in this follow up study. Between 09/2004 and 10/2010 a total of 330 patients underwent biological AVR using the LABCOR porcine bioprotheses. Concomitant bypass surgery was performed in 130 cases. Preoperatively, 69 patients (21%) were in NYHA class II, 214 (65%) in class III and 47 (14%) in class IV.
Results:
The follow up rate was 98%. The 30 day mortality rate amounted 4,8% (n=16). There was no evidence of valve failure during this period. Mean follow up was 5,6 patient years. Total follow up 1.441 patient years. 5 year survival amounted 60% (±1,4), 8 year survival 49% (±1,6). 50% (n=89) of the contacted patients were NYHA Class I 39% (n=69) in NYHA Class II 10% (n=18) and 0,6% (n=1) in NYHA class IV. Out of 136 late deaths 9 were valves related (0,6%/pt-year) with 1 case of paravalvular leakage, 6 cases of endocarditis, one stroke and one patient who suffered from cerebral hemorrhage. 26 late deaths were cardiac (1,8%/pt-year), 49 were noncardiac (3,4%/pt-year) and 56 were unexplained (3,9%/pt-year).
Adverse events:
Frequency of adverse events and actuarial freedom from valve related adverse events 5 years and 8 years after aortic valve replacement. 
Conclusion:
In this middle follow-up term of 8 years of clinical experience in a single center, the LABCOR porcine bioprosthesis shows reliable and satisfying results comparable to other commercial porcine heart valves in a patient group with a medium risk profile. Nevertheless, further long-term assessment and echocardiographic examination is needed. Schlömicher M.; Haldenwang P.L.; Buchwald D.; Laczkovics A.; Bechtel M.; Moustafine V.; Strauch J.; Klinik für Herz-Thoraxchirurgie, Berufsgenissenschaftliches Universitätsklinikum Bergmannsheil Bochum 
years experience with the LABCOR bioprosthesis in the Aortic position

Background:
Between 2004 and 2010 330 patients with a mean age of 75,8 ± 7,2 years and mean logistic EuroSCORE of 8,5% underwent AVR with the LABCOR TLPB-A Supra porcine bioprosthesis in our institution. This papers presents clinical results against the background following a trend towards bovine devices through the last decade.
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